Endogenous tissue repair pathways

Endogenous tissue repair pathways represent the body's intrinsic biological mechanisms for restoring structural and functional integrity following injury or disease. These pathways involve a highly coordinated sequence of events, including the activation of resident stem cells, cell migration, proliferation, and the remodeling of the extracellular matrix (Source: Nature Reviews Molecular Cell Biology). Key signaling cascades such as Wnt, Notch, Hedgehog, and TGF-beta serve as the primary regulators of these processes, determining whether a tissue undergoes functional regeneration or maladaptive fibrotic scarring (Source: Science). In many pathological states, such as chronic obstructive pulmonary disease or myocardial infarction, these endogenous mechanisms are impaired or exhausted, leading to progressive organ failure. Therapeutic targeting of these pathways, often termed regenerative pharmacology, aims to enhance or restart these innate processes using small molecules, growth factors, or gene therapies (Source: Journal of Clinical Investigation). For example, drugs may target the TGF-beta pathway to reduce fibrosis or the Wnt pathway to stimulate cartilage repair in osteoarthritis. However, a significant challenge in modulating these pathways is their dual role in development and cancer; over-activation of pro-regenerative signals can lead to uncontrolled cell growth and tumor formation (Source: Nature Reviews Drug Discovery). Consequently, therapeutic interventions must be precisely controlled in terms of timing and localization to ensure safety and efficacy.

Other names

Endogenous regenerative pathwaysInnate repair mechanismsTissue regeneration signaling cascades

Pharmacological modulation of intrinsic signaling networks, such as the Wnt, Notch, and TGF-beta pathways, to activate quiescent resident progenitor cells and coordinate the replacement of damaged tissue with functional cellular components rather than non-functional scar tissue.